-

Trinity Life Sciences Secures Prestigious Leader Position in Everest Group’s 2025 PEAK Matrix® for Life Sciences AI & Analytics Excellence

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in advisory, insights and analytics for the life sciences industry, today announced its recognition as a Leader in Everest Group’s 2025 PEAK Matrix® for Life Sciences AI and Analytics. Trinity Life Sciences was one of only ten companies to achieve Leader status.

"We are thrilled to be recognized as a Leader in Everest Group's 2025 PEAK Matrix® for Life Sciences AI and Analytics," said Leslie Orne, President and CEO of Trinity Life Sciences. "As commercialization strategies rapidly evolve toward data and AI-driven approaches, our team remains dedicated to empowering clients with expertise and technology that deliver measurable results."

The Everest Group PEAK Matrix® is a comprehensive framework that assesses the overall vision, capability, and market impact of platform providers. The 2025 report evaluated 30 service providers, classifying them into Leaders, Major Contenders, and Aspirants. The assessment is based on Everest Group’s PEAK Matrix® Request For Information process for the calendar year 2024, interactions with leading life sciences commercial providers, client reference checks, and an ongoing analysis of the life sciences digital services market.

“The growing emphasis on patient- and HCP-centricity to deliver superior customer experiences has modernized commercialization strategies, placing data, analytics, and AI at the core of life sciences enterprises' go-to-market efforts. As a result, they are turning to strategic partners with domain-led digital expertise and scalable technology solutions to navigate the evolving landscape,” says Durga Ambati, Vice President at Everest Group.

“Trinity Life Sciences' generative and agentic AI investments, the TrinityEDGE™ suite of commercial solutions, its targeted domain-centric partnerships, and its thought leadership are augmented by its client flexibility and responsiveness. This focus has led to its recognition as a Leader in Everest Group’s Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment 2025.”

Trinity Life Sciences was specifically recognized for several key areas, including:

  • Specialized products spanning commercialization such as Customer Engagement Orchestrator, RealWorldEDGE, and Launch Accelerator™.
  • GenAI and agentic AI solutions like Field and MSL Advisor.
  • Strategic partnerships that enhance its capabilities portfolio, such as with Ontada, a McKesson business.
  • Client appreciation for Trinity's account structure and responsiveness, particularly its single-point-of-contact model.
  • Robust ability to support data warehousing, integration, and analytics strategy.

Trinity's recognition in the Everest Group PEAK Matrix® reflects its proven ability to drive measurable ROI across commercialization, ensuring clients see real value faster. With industry-leading GenAI solutions like MSL Advisor, Trinity brings scalable innovation built for the nuances of its clients' businesses.

Disclaimer

Licensed extracts taken from Everest Group’s PEAK Matrix® Reports may be used by licensed third parties for use in their own marketing and promotional activities and collateral. Selected extracts from Everest Group’s PEAK Matrix® reports do not necessarily provide the full context of our research and analysis. All research and analysis conducted by Everest Group’s analysts and included in Everest Group’s PEAK Matrix® reports is independent and no organization has paid a fee to be featured or to influence their ranking. To access the complete research and to learn more about our methodology, please visit Everest Group PEAK Matrix® Reports.

About Trinity Life Sciences

With almost 30 years of expertise, a best-in-the-business team and unrivaled access to data and analytics, Trinity Life Sciences is a modern partner to companies in the life sciences industry. Trinity combines strategy, insights and analytics to help life science executives with clinical and commercial decision-making. Ultimately, we know that every decision our clients make impacts a life, and when we help our clients achieve their goals, the world benefits. To learn more about how Trinity is elevating the industry and driving evidence to action, visit TrinityLifeSciences.com.

Contacts

Trinity Life Sciences


Release Versions

Contacts

More News From Trinity Life Sciences

Trinity Life Sciences Unveils Breakthrough AI Model That Detects Type 1 Diabetes a Year Before Symptoms Appear

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in advisory, insights and analytics for the life sciences industry, presented results from a new study demonstrating the potential of an artificial intelligence and machine learning (AIML) model to detect type 1 diabetes (T1D) at least one year before a patient’s clinical diagnosis. Leveraging Trinity’s leading-edge AI capabilities and deep therapeutic expertise, with support from Sanofi, the model also maintains improved accuracy...

Trinity Life Sciences Unveils Critical Insights for Navigating the Path From Initial Generative AI Adoption to Full-Scale Transformation

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in advisory, insights and analytics for the life sciences industries, discusses the journey to achieving successful transformation with generative AI (GenAI) in a new white paper, entitled Technology with a Point of View: Encoding Life Sciences Expertise with AI. GenAI is a technological disruption with significant potential to revolutionize biopharmaceutical commercialization across functions and use cases by: Changing how life...

Trinity Life Sciences Expands Data Partnership Network to Revolutionize Commercialization in Community Oncology

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in advisory, insights and analytics for the life sciences industries, announces a strategic collaboration with Ontada, a McKesson business and leader in community oncology real-world data, clinical education and point-of-care technologies. This relationship will provide life sciences companies with real-time, actionable intelligence and critical insights to drive strategic decisions both pre- and post-product launch. Together, the...
Back to Newsroom